M&G Investments has made a $57 million investment with Swiss-based tech firm, SkyCell and says it is seeking to change the face of international pharma supply chains.
Driven by market demand, De Dietrich develops an API production set that enables continuous manufacturing of molecules that require exothermic chemical reactions.
Partnering with airlines is essential, says CSafe executive, as the company signs an agreement to use LOT Cargo’s to airplanes to transporttemperature-sensitive biologics.